Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07458984 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FMT Capsules for rCDI

Study acronym: FMT CAP CDI
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Start date changed from estimate of Feb 25, 2026 to Apr 25, 2026
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Trial Details
NCT Number NCT07458984
Lead Sponsor Helsinki University Central Hospital
Conditions
(from sponsor)		 Clostridioides Difficile Infection Recurrence, FMT
Related terms Clostridium Infections
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov